CLB vs NOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

CLB

47.2
AI Score
VS
NOV Wins

NOV

52.3
AI Score

Investment Advisor Scores

CLB

47score
Recommendation
HOLD

NOV

52score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CLB NOV Winner
Revenue 378.48M 6.41B NOV
Net Income 10.61M 221.00M NOV
Net Margin 2.8% 3.4% NOV
Operating Income 23.10M 382.00M NOV
ROE 3.8% 3.5% CLB
ROA 1.8% 2.0% NOV
Total Assets 593.52M 11.22B NOV
Cash 21.38M 1.06B NOV
Debt/Equity 0.41 0.27 NOV
Current Ratio 2.19 2.51 NOV
Free Cash Flow 5.36M -202.00M CLB

Relative Price Performance (Last 90 Days)

CLB 1M: -7.8% · 3M: -27.6% NOV 1M: -5.1% · 3M: -15.8%

Current Technical Phase

CLB

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.7%), weak momentum, RSI 36

RSI (14): 36.0 · Price: $9.01

NOV

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.9%), weak momentum, RSI 39

RSI (14): 39.4 · Price: $17.80

Fundamentals Snapshot

Metric CLB NOV
Market Cap — —
Forward P/E 13.1 13.8
Trailing P/E 26.6 43.9
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.2% 0.2%
Operating Margin 0.1% 0.1%
EPS 0.34 0.41
Dividend Yield 0.00% 0.02%

Frequently Asked Questions

Based on our detailed analysis, NOV is currently the stronger investment candidate, winning 9 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.